期刊文献+

三维适形放疗联合GP方案同步治疗局部晚期非小细胞肺癌临床观察 被引量:7

Clinical observation of three dimensional conformal radiotherapy combined with GP regimen chemotherapy in treatment of locally advanced non-small cell lung cancer.
下载PDF
导出
摘要 目的探讨三维适形放疗联合GP方案同步化疗治疗局部晚期非小细胞肺癌的近期疗效和急性毒副反应。方法40例Ⅲ期非小细胞肺癌患者采用三维适形放疗,同时予GP方案化疗(G:吉西他滨1000mg/m^2,第l,8天;P:顺铂30mg/m^2,第1-3天,每28天1个周期)。结果肺原发灶总有效率为85%;纵隔转移淋巴结总有效率为91.9%,急性毒副反应主要是骨髓抑制、胃肠道反应和轻中度放射性食管炎、放射性肺炎,均可耐受。结论三维适形放疗与GP方案同步放化疗治疗局部晚期非小细胞肺癌有较好近期疗效。 To explore clinical short-term effect and acute side effects of three dimensional conformal radiotherapy (3DCRT) ( combined with GP regimen chemotherapy in treatment of locally advanced non-small cell lung cancer (NSCLC). Methods Forty patients of NSCLC Stage Ⅲ were treated with 3DCRT combined with GP regimen chemotherapy ( G:gcmeitabine 1000 mg,/m2 d1:8 ; P:eisplatin 30mg/m2 dl ~3. Each cycle took 20 days in completion. Results The overall response rate was 85% for primary tumor, and 91.9% for metastatic mediastinal lymph nodes. The acute side effects were mostly bone marrow suppression, nausea, vomiting, radiation-induced esophagitis and pneumonitis ( RTOPG I / Ⅲ ) with good tolerance. Conclusion 3DCRT combined with GP is well tolerated in most patients with locally advanced NSCLC. Its short-term clinical effect is good.
出处 《临床肺科杂志》 2007年第10期1039-1040,共2页 Journal of Clinical Pulmonary Medicine
关键词 非小细胞肺癌 三维适形放疗 化疗 同步放化疗 NSCLC 3DCRT chemotherapy concurrent chemoradiotherapy
  • 相关文献

参考文献9

二级参考文献16

  • 1冷嘉兴,徐建忠,孙毅,徐珍,孔颖泽.吉西他滨联合顺铂治疗晚期非小细胞肺癌的临床研究[J].现代肿瘤医学,2005,13(3):393-394. 被引量:6
  • 2徐波,赵敬生,赵晓艾,李恩孝.GP方案治疗晚期非小细胞肺癌疗效观察[J].现代肿瘤医学,2006,14(1):44-45. 被引量:4
  • 3殷蔚伯 谷铣之.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2003.1041-1042.
  • 4孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,2003.586-591.
  • 5Socinski NA.Cytotoxic chemotherapy in advanced non-small cell lung cancer:a review of standard treatment paradigms [J].Clin Cancer Res,2004,10(2):4210 ~4214.
  • 6Paul A, Bunn J. Triplit chemotherapy with gemcitabin, a platinum and third agent in the treatment of advanced non-small cell lung .cancer[J].J Semin Oncol, 1999,26(1):25-30.
  • 7Sendler A, Michael J, David A, et al. Phase Ⅲ trial of gemeitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non small cell lung cancer [J]. J Clin Oncol, 2000, 18: 122-130.
  • 8Nevmark N, Lianes P, Smit EF, et al. Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancer[J].Pharmacoeconomics, 2005,23(11):1155-1166.
  • 9Kim JH,Kim SY,Jung KH,et al.Randomized phase Ⅱ study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer.Korean Cancer Study Group experience[J].Lung Cancer,2006,52(1):75-81.
  • 10Moscetti L,Nelli F, Padalino D, et al. Gemcitabine and cisplatin in the treatment of elderly patients with advanced non-small cell lung cancer, impact of comorbidities on safety and efficacy outcome[J]. J Chemother, 2005,17(6):685-692.

共引文献125

同被引文献38

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部